BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 12034032)

  • 1. Mechanisms for regulation of cellular responsiveness to human IFN-beta1a.
    Dupont SA; Goelz S; Goyal J; Green M
    J Interferon Cytokine Res; 2002 Apr; 22(4):491-501. PubMed ID: 12034032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferons up-regulate STAT1, STAT2, and IRF family transcription factor gene expression in human peripheral blood mononuclear cells and macrophages.
    Lehtonen A; Matikainen S; Julkunen I
    J Immunol; 1997 Jul; 159(2):794-803. PubMed ID: 9218597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low expression of interferon-stimulated genes in active multiple sclerosis is linked to subnormal phosphorylation of STAT1.
    Feng X; Petraglia AL; Chen M; Byskosh PV; Boos MD; Reder AT
    J Neuroimmunol; 2002 Aug; 129(1-2):205-15. PubMed ID: 12161037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells.
    Schaber JD; Fang H; Xu J; Grimley PM; Rui H
    Cancer Res; 1998 May; 58(9):1914-9. PubMed ID: 9581833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins.
    David M; Petricoin E; Benjamin C; Pine R; Weber MJ; Larner AC
    Science; 1995 Sep; 269(5231):1721-3. PubMed ID: 7569900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An essential role for IFN-alpha in the overexpression of Fas ligand on MRL/lpr lymphocytes and on their spontaneous Fas-mediated cytotoxic potential.
    Hadj-Slimane R; Chelbi-Alix MK; Tovey MG; Bobé P
    J Interferon Cytokine Res; 2004 Dec; 24(12):717-28. PubMed ID: 15684739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CpG-DNA-induced IFN-alpha production involves p38 MAPK-dependent STAT1 phosphorylation in human plasmacytoid dendritic cell precursors.
    Takauji R; Iho S; Takatsuka H; Yamamoto S; Takahashi T; Kitagawa H; Iwasaki H; Iida R; Yokochi T; Matsuki T
    J Leukoc Biol; 2002 Nov; 72(5):1011-9. PubMed ID: 12429724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of beta-R1, a gene that is selectively induced by interferon beta (IFN-beta) compared with IFN-alpha.
    Rani MR; Foster GR; Leung S; Leaman D; Stark GR; Ransohoff RM
    J Biol Chem; 1996 Sep; 271(37):22878-84. PubMed ID: 8798467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional significance of globotriaosyl ceramide in interferon-alpha(2)/type 1 interferon receptor-mediated antiviral activity.
    Khine AA; Lingwood CA
    J Cell Physiol; 2000 Jan; 182(1):97-108. PubMed ID: 10567921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells.
    Gautier G; Humbert M; Deauvieau F; Scuiller M; Hiscott J; Bates EE; Trinchieri G; Caux C; Garrone P
    J Exp Med; 2005 May; 201(9):1435-46. PubMed ID: 15851485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential responsiveness to IFN-alpha and IFN-beta of human mature DC through modulation of IFNAR expression.
    Severa M; Remoli ME; Giacomini E; Ragimbeau J; Lande R; Uzé G; Pellegrini S; Coccia EM
    J Leukoc Biol; 2006 Jun; 79(6):1286-94. PubMed ID: 16624932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-beta is a potent inducer of interferon regulatory factor-1/2-dependent IP-10/CXCL10 expression in primary human endothelial cells.
    Buttmann M; Berberich-Siebelt F; Serfling E; Rieckmann P
    J Vasc Res; 2007; 44(1):51-60. PubMed ID: 17167270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoic acid induces signal transducer and activator of transcription (STAT) 1, STAT2, and p48 expression in myeloid leukemia cells and enhances their responsiveness to interferons.
    Matikainen S; Ronni T; Lehtonen A; Sareneva T; Melén K; Nordling S; Levy DE; Julkunen I
    Cell Growth Differ; 1997 Jun; 8(6):687-98. PubMed ID: 9186002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential recognition of the type I interferon receptor by interferons tau and alpha is responsible for their disparate cytotoxicities.
    Subramaniam PS; Khan SA; Pontzer CH; Johnson HM
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12270-4. PubMed ID: 8618883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promotion of alpha/beta interferon induction during in vivo viral infection through alpha/beta interferon receptor/STAT1 system-dependent and -independent pathways.
    Malmgaard L; Salazar-Mather TP; Lewis CA; Biron CA
    J Virol; 2002 May; 76(9):4520-5. PubMed ID: 11932417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of gene expression patterns induced by treatment of human umbilical vein endothelial cells with IFN-alpha 2b vs. IFN-beta 1a: understanding the functional relationship between distinct type I interferons that act through a common receptor.
    da Silva AJ; Brickelmaier M; Majeau GR; Lukashin AV; Peyman J; Whitty A; Hochman PS
    J Interferon Cytokine Res; 2002 Feb; 22(2):173-88. PubMed ID: 11911800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous levels of mRNA for IFNs and IFN-related genes in hepatic biopsies of chronic HCV-infected and non-alcoholic steatohepatitis patients.
    Abbate I; Romano M; Longo R; Cappiello G; Lo Iacono O; Di Marco V; Paparella C; Spano A; Capobianchi MR
    J Med Virol; 2003 Aug; 70(4):581-7. PubMed ID: 12794720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to interferons in melanoma cells does not correlate with the expression or activation of signal transducer and activator of transcription 1 (Stat1).
    Chawla-Sarkar M; Leaman DW; Jacobs BS; Tuthill RJ; Chatterjee-Kishore M; Stark GR; Borden EC
    J Interferon Cytokine Res; 2002 May; 22(5):603-13. PubMed ID: 12060499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFN-beta is a highly potent inhibitor of gastroenteropancreatic neuroendocrine tumor cell growth in vitro.
    Vitale G; de Herder WW; van Koetsveld PM; Waaijers M; Schoordijk W; Croze E; Colao A; Lamberts SW; Hofland LJ
    Cancer Res; 2006 Jan; 66(1):554-62. PubMed ID: 16397272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping of IFN-beta epitopes important for receptor binding and biologic activation: comparison of results achieved using antibody-based methods and alanine substitution mutagenesis.
    Runkel L; De Dios C; Karpusas M; Baker D; Li Z; Zafari M; Betzenhauser M; Muldowney C; Miller S; Redlich PN; Grossberg SE; Whitty A; Hochman PS
    J Interferon Cytokine Res; 2001 Nov; 21(11):931-41. PubMed ID: 11747625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.